Vandria is a clinical stage biotech company developing first-in-class small molecules against a novel target to restore mitochondrial function and reduce inflammation for the treatment of age-related and chronic diseases
Vandria is a clinical stage biotech company developing first-in-class small molecules against a novel target to restore mitochondrial function and reduce inflammation for the treatment of age-related and chronic diseases.